Nephrodite Inc., a medical device company developing an implantable, continuous dialysis system, today announced successful results from a multi-day large animal study of its Holly(TM) implantable ...

Holly™ by Nephrodite becomes the first device to achieve the designation, marking a major regulatory milestone toward first-in-human clinical studies Nephrodite, Inc., a medical device company ...

Nephrodite Inc.'s Holly, an implantable, continuous renal replacement system, received U.S. FDA breakthrough device designation as a novel and potentially life-changing treatment for end-stage kidney ...

Please provide your email address to receive an email when new articles are posted on . Nephrodite received breakthrough status to pursue steps for eventual testing in humans. The device, implanted in ...

This article is part of a series of profiles on the 2020 winners of the National Academy of Medicine’s Healthy Longevity Catalyst Awards — part of the Healthy Longevity Global Competition, a multiyear ...

ATLANTA, December 09, 2025--(BUSINESS WIRE)--Nephrodite Inc., a medical device company developing an implantable, continuous dialysis system, today announced successful results from a multi-day large ...

Nephrodite, Inc., a medical device company developing an implantable, continuous renal replacement system, today announced that the U.S. Food and Drug Administration (FDA) has granted Breakthrough ...

This article is part of a series of profiles on the 2020 winners of the National Academy of Medicine’s Healthy Longevity Catalyst Awards — part of the Healthy Longevity Global Competition, a multiyear ...

The Holly™ by Nephrodite device demonstrated continuous kidney function replacement in a large animal marking a critical milestone toward commercialization Nephrodite Inc., a medical device company ...